CANCARINI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 9.956
EU - Europa 6.389
AS - Asia 2.609
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 13
OC - Oceania 13
SA - Sud America 11
Totale 19.005
Nazione #
US - Stati Uniti d'America 9.927
PL - Polonia 1.532
UA - Ucraina 1.444
IT - Italia 1.409
CN - Cina 1.379
DE - Germania 622
SG - Singapore 518
FI - Finlandia 340
HK - Hong Kong 330
GB - Regno Unito 243
RU - Federazione Russa 215
FR - Francia 213
IE - Irlanda 212
TR - Turchia 191
IN - India 79
BE - Belgio 51
VN - Vietnam 46
SE - Svezia 34
CA - Canada 24
CZ - Repubblica Ceca 20
IR - Iran 19
ID - Indonesia 17
NL - Olanda 16
AU - Australia 13
EU - Europa 13
BR - Brasile 9
ES - Italia 9
BD - Bangladesh 7
EG - Egitto 5
PK - Pakistan 5
RO - Romania 5
CH - Svizzera 4
JP - Giappone 4
AZ - Azerbaigian 3
BG - Bulgaria 3
LV - Lettonia 3
MX - Messico 3
ZA - Sudafrica 3
AT - Austria 2
HR - Croazia 2
KR - Corea 2
KZ - Kazakistan 2
MA - Marocco 2
MU - Mauritius 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
EE - Estonia 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
LU - Lussemburgo 1
NG - Nigeria 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 19.005
Città #
Warsaw 1.531
Fairfield 1.359
Woodbridge 1.150
Jacksonville 1.048
Houston 777
Ashburn 707
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 502
Wilmington 463
Singapore 425
Princeton 418
Nanjing 366
Hong Kong 328
Dublin 210
New York 187
Istanbul 176
Beijing 172
Helsinki 161
Milan 144
Nanchang 136
Dearborn 113
Des Moines 103
Brescia 91
Hebei 82
Moscow 77
Shenyang 77
Jiaxing 76
Rome 76
San Diego 73
Changsha 68
Tianjin 66
Jinan 52
Verona 48
Brussels 47
Shanghai 45
Dong Ket 44
Munich 40
Kunming 38
Boardman 34
Hangzhou 28
Lanzhou 27
London 24
Naples 24
Ningbo 24
San Mateo 23
Brno 20
Lancaster 20
Falls Church 19
Augusta 18
Monmouth Junction 18
Toronto 17
Zhengzhou 17
Leawood 16
Ardabil 15
Florence 15
Jakarta 15
Turin 15
Bari 14
Bologna 14
Norwalk 14
Palermo 14
San Francisco 14
Taizhou 14
Haikou 13
Los Angeles 13
Bergamo 12
Changchun 12
Kocaeli 12
Genoa 10
Orange 10
Atlanta 8
Dallas 8
Guangzhou 8
Napoli 8
Avellino 7
Catania 7
Edinburgh 7
Hefei 7
Kilburn 7
Padova 7
Melbourne 6
Mumbai 6
Phoenix 6
Prato 6
Redwood City 6
Taiyuan 6
Trieste 6
Venice 6
Canberra 5
Chiswick 5
Falkenstein 5
Foggia 5
Genova 5
New Rochelle 5
Perugia 5
Pisa 5
Pune 5
Rovato 5
Totale 14.005
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 911
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 368
Incremental peritoneal dialysis: a 10 year single-centre experience 273
Low-protein diets for chronic kidney disease patients: The Italian experience 228
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 222
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 192
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 189
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 185
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 181
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 180
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 180
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 179
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 178
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 173
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 172
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 164
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 159
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 154
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 151
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 148
Nutritional treatment of advanced CKD: twenty consensus statements 140
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 127
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 127
Differing dialysis treatment strategies and outcome. 126
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 124
The MEST score provides earlier risk prediction in lgA nephropathy 121
Vascular access in older patients: an Italian survey. 121
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 120
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 119
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 117
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 117
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 116
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 115
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 115
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 114
Assessment of calcemic status in dialyzed uraemic patients. 113
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 111
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 110
Diethylene Glycol Poisoning From Transcutaneous Absorption 109
A six year comparison of patient and technique survivals in CAPD and HD 109
Dialysis initiation: what's the rush? 108
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 108
Which vascular access for chronic hemodialysis in uremic elderly patients? 107
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 107
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 107
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 106
Clinical policies on the management of chronic kidney disease patients in Italy. 105
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 105
A more tubulocentric view of diabetic kidney disease 105
Experience with cyclosporine. 104
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 104
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 103
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 103
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 103
Porphyria and pseudo-porphyria in hemodialyzed patients. 102
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 102
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 101
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 100
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 100
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 100
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 99
Porphyria cutanea tarda in a haemodialysed patient. 99
Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. 99
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 98
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 98
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 97
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 96
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 96
Myocardial ultrasound tissue characterization in patients with chronic renal failure 95
Kidney transplantation in HIV-positive patients: a report of 14 cases 95
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 94
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics 94
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 94
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 93
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 93
Kidney transplantation in hiv-positive patients treated with a steroid-free immunosuppressive regimen. 92
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 92
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 92
Impact of European medicines agency recommendations for hypersensitivity reactions on intravenous iron prescription in haemodialysis centres of the Lombardy region 92
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 91
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 91
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 91
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 91
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 91
Renal anemia: comparing current Eastern and Western European management practice (ORAMA). 91
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 91
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 91
Strategy for preventing peritoneal dialysis failure. 89
Transplantation outcome in patients PD and HD 89
The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients 89
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 88
Fistula maturation: doesn't time matter at all? 88
PD or not PD? That is the question. 87
Pulmonary calciphylaxis and metastatic calcification with acute respiratory failure in multiple myeloma. 87
Outcome of peritoneal dialysis: comparative studies. 86
Plasma exchange in the treatment of acute renal failure of myeloma. 86
De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997-2012 86
Renal transplantation and peritoneal dialysis 85
Well being in patients on CAPD and hemodialysis. 85
Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). 84
Totale 12.703
Categoria #
all - tutte 86.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.041


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.485 0 0 0 0 0 0 460 572 360 580 187 326
2020/20213.348 92 378 159 408 149 380 141 377 485 262 358 159
2021/20221.692 114 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/20251.313 50 78 44 363 486 291 1 0 0 0 0 0
Totale 19.287